Suche Bilder Maps Play YouTube News Gmail Drive Mehr »
Anmelden
Nutzer von Screenreadern: Klicke auf diesen Link, um die Bedienungshilfen zu aktivieren. Dieser Modus bietet die gleichen Grundfunktionen, funktioniert aber besser mit deinem Reader.

Patentsuche

  1. Erweiterte Patentsuche
VeröffentlichungsnummerUS5769880 A
PublikationstypErteilung
AnmeldenummerUS 08/632,516
Veröffentlichungsdatum23. Juni 1998
Eingetragen12. Apr. 1996
Prioritätsdatum12. Apr. 1996
GebührenstatusBezahlt
Auch veröffentlicht unterCA2251216A1, CN1220590A, DE69733556D1, DE69733556T2, DE69739697D1, EP0898465A2, EP0898465B1, EP1415607A1, EP1415607B1, WO1997038637A1
Veröffentlichungsnummer08632516, 632516, US 5769880 A, US 5769880A, US-A-5769880, US5769880 A, US5769880A
ErfinderCsaba Truckai, David C. Auth
Ursprünglich BevollmächtigterNovacept
Zitat exportierenBiBTeX, EndNote, RefMan
Externe Links: USPTO, USPTO-Zuordnung, Espacenet
Moisture transport system for contact electrocoagulation
US 5769880 A
Zusammenfassung
An apparatus and method for use in performing ablation of organs and other tissue includes an electrode carrying member which is substantially absorbent and/or permeable to moisture. The electrode carrying member is mounted to the distal end of an elongate shaft, and an array of electrodes is mounted to the surface of the electrode carrying member. Following placement of the ablation device into contact with the tissue to be ablated, an RF generator is used to deliver RF energy to the electrodes and to thereby induce current flow from the electrodes to tissue to be ablated. As the current heats the tissue, moisture (such as water vapor or liquid) leaves the tissue causing the tissue to dehydrate. The moisture permeability and/or absorbency of the electrode carrying member allows the moisture to leave the ablation site so as to prevent the moisture from providing a path of conductivity for the current.
Bilder(7)
Previous page
Next page
Ansprüche(33)
We claim:
1. An ablation and/or coagulation apparatus for use in delivering energy to tissue for ablation, the apparatus comprising:
a moisture permeable and/or absorbable electrode carrying member configured to permit moisture generated during ablation to pass into the electrode carrying member and away from underlying tissue;
electrodes mounted to the electrode carrying member; and
means for delivering radio frequency energy to the electrodes.
2. The apparatus of claim 1 wherein the electrode carrying member is formed of sponge.
3. The apparatus of claim 1 wherein the electrode carrying member is formed of foam.
4. The apparatus of claim 1 wherein the electrode carrying member is formed of a porous filler material.
5. The apparatus of claim 1 wherein the electrode carrying member is further formed of conformable material.
6. The ablation apparatus of claim 1 further comprising structural support means within the electrode carrying member.
7. The ablation apparatus of claim 6 wherein the structural support means includes an inflatable balloon.
8. The ablation apparatus of claim 6 wherein the structural support means comprises spring members positioned within the electrode carrying member.
9. The ablation apparatus of claim 8 wherein the spring members are moveable between a closed condition and an opened condition.
10. The ablation apparatus of claim 1 further comprising at least one contact sensor carried by the electrode carrying member and means for measuring impedance.
11. A method of ablating and/or coagulating tissue, comprising the steps of:
(a) providing an electrode carrying member with electrodes thereon;
(b) positioning the electrodes in contact with tissue to be ablated;
(c) passing current through the electrodes to the tissue to cause the tissue to dehydrate; and
(d) permitting moisture generated during the dehydration of step (c) to pass into the electrode carrying member and away from the tissue.
12. The method of claim 11 wherein the tissue has a surface and wherein step (b) includes the step of causing the electrode carrying member to conform to the shape of the tissue surface.
13. The method of claim 11 wherein the method further includes the step of
(e) automatically terminating the flow of current into the tissue once ablation has approximately reached a predetermined depth or level of dehydration.
14. The method of claim 11 wherein the method further includes the steps of:
(e) monitoring the impedance of the tissue undergoing ablation; and
(f) terminating the ablation procedure once the impedance has reached a predetermined level.
15. The method of claim 11 wherein step (c) includes the step of passing current through select ones of the electrodes.
16. The method of claim 11 including the step of applying suction through the electrode carrying means to draw the tissue into contact with the electrode carrying means and the electrodes to facilitate moisture removal.
17. A method of ablating and/or coagulating tissue, comprising the steps of:
(a) providing an elongate tube and providing an electrode carrying member with electrodes thereon on a distal portion of the tube;
(b) positioning the electrodes in contact with tissue to be ablated;
(c) passing current through the electrodes to the tissue to cause the tissue to dehydrate; and
(d) permitting moisture generated during the dehydration of step (c) to pass into the electrode carrying member and away from the tissue and permitting at least a portion of the moisture to pass from the electrode carrying member through the tube.
18. The method of claim 17 wherein step (d) includes the step of applying suction to the tube to draw the moisture through the tube.
19. An ablation and/or coagulation apparatus for use in delivering energy to tissue for ablation, the apparatus comprising:
an elongate tube;
a moisture permeable and/or absorbable electrode carrying member mounted to the tube, the tube including a plurality of aeration openings underlying the electrode carrying member;
electrodes mounted to the electrode carrying member; and
means for delivering radio frequency energy to the electrodes.
20. An ablation and/or coagulation apparatus for use in delivering energy to tissue for ablation, the apparatus comprising:
a moisture permeable and/or absorbable electrode carrying member;
electrodes mounted to the electrode carrying member;
means for delivering radio frequency energy to the electrodes; and
suction means for drawing moisture away from the electrode carrying member.
21. An ablation and/or coagulation apparatus for use in delivering energy to tissue for ablation, the apparatus comprising:
an elongate tube;
a moisture permeable and/or absorbable electrode carrying member mounted to the tube;
electrodes mounted to the electrode carrying member;
means for delivering radio frequency energy to the electrodes; and
suction means for drawing moisture through the tube away from the electrode carrying member.
22. An apparatus for intrauterine ablation, comprising:
an elongate tube;
an electrode carrying pad mounted to the tube and shaped to approximate the shape of a uterus;
an array of electrodes mounted to the pad;
means for delivering RF energy to the electrodes to cause current flow from the electrodes to tissue to be ablated; and
means for automatically terminating the flow of current from the electrodes to the tissue once a predetermined ablation depth has been substantially reached.
23. The apparatus of claim 22 further comprising means for drawing moisture from tissue undergoing ablation into the electrode carrying pad.
24. A method of ablating tissue, comprising the steps of:
(a) providing an electrode carrying member with electrodes thereon;
(b) positioning the electrodes in contact with tissue to be ablated;
(c) selecting a depth to which ablation is to be carried out; and
(d) delivering RF energy to the tissue through select ones of the electrodes to cause ablation of the tissue to approximately the selected ablation depth and to cause automatic termination of current flow into the tissue once the selected ablation depth has been approximately reached.
25. A method of ablating tissue, comprising the steps of:
(a) providing an electrode carrying member with electrodes thereon;
(b) positioning the electrodes in contact with tissue to be ablated;
(c) selecting a depth to which ablation is to be carried out; and
(d) selecting an effective electrode spacing which would produce ablation to approximately the desired ablation depth, and delivering RF energy to select ones of the electrodes such that the spacing between the energized electrodes is substantially the selected effective electrode spacing, to cause ablation of the tissue to approximately the selected ablation depth.
26. A method of ablating tissue, comprising the steps of:
(a) providing an electrode carrying member with electrodes thereon;
(b) positioning the electrodes in contact with tissue to be ablated;
(c) selecting a depth to which ablation is to be carried out; and
(d) selecting an electrode surface density which will produce ablation to approximately the desired ablation depth, and delivering RF energy to select ones of the electrodes such that the electrode surface density of the energized electrodes is substantially the selected electrode surface density, to cause ablation of the tissue to approximately the selected ablation depth.
27. An ablation and/or coagulation apparatus for use in delivering energy to tissue for ablation, the apparatus comprising:
an electrode member formed of a metallized fabric having insulating regions formed thereon; and
a source of RF energy electrically coupled to the metallized fabric.
28. The apparatus of claim 27 wherein the electrode member is mounted to an elongate member.
29. The apparatus of claim 28 wherein the elongate member is tubular.
30. The apparatus of claim 27 wherein the metallized fabric is moisture permeable.
31. The apparatus of claim 30 further comprising a vacuum source fluidly coupled to the electrode member to actively draw moisture away from underlying tissue.
32. The apparatus of claim 31 wherein the electrode member is mounted to an elongate tubular member and wherein the vacuum source is fluidly coupled to the electrode member to actively draw moisture away from underlying tissue and into the elongate tubular member.
33. The apparatus of claim 27 wherein the insulating regions are etched onto the metallized fabric.
Beschreibung
FIELD OF THE INVENTION

The present invention relates generally to the field of apparatuses and methods for ablating or coagulating the interior surfaces of body organs. Specifically, it relates to an apparatus and method for ablating the interior linings of body organs such as the uterus and gallbladder.

BACKGROUND OF THE INVENTION

Ablation of the interior lining of a body organ is a procedure which involves heating the organ lining to temperatures which destroy the cells of the lining or coagulate tissue proteins for hemostasis. Such a procedure may be performed as a treatment to one of many conditions, such as chronic bleeding of the endometrial layer of the uterus or abnormalities of the mucosal layer of the gallbladder. Existing methods for effecting ablation include circulation of heated fluid inside the organ (either directly or inside a balloon), laser treatment of the organ lining, and resistive heating using application of RF energy to the tissue to be ablated.

U.S. Pat. No. 5,084,044 describes an apparatus for endometrial ablation in which a bladder is inserted into the uterus. Heated fluid is then circulated through the balloon to expand the balloon into contact with the endometrium and to ablate the endometrium thermally. U.S. Pat. No. 5,443,470 describes an apparatus for endometrial ablation in which an expandable bladder is provided with electrodes on its outer surface. After the apparatus is positioned inside the uterus, a non-conductive gas or liquid is used to fill the balloon, causing the balloon to push the electrodes into contact with the endometrial surface. RF energy is supplied to the electrodes to ablate the endometrial tissue using resistive heating.

These ablation devices are satisfactory for carrying out ablation procedures. However, because no data or feedback is available to guide the physician as do how deep the tissue ablation has progressed, controlling the ablation depth and ablation profile with such devices can only be done by assumption.

For example, heated fluid method is a very passive and ineffective heating process which relies on the heat conductivity of the tissue. This process does not account for variations in factors such as the amount of contact between the balloon and the underlying tissue, or cooling effects such as those of blood circulating through the organ. RF ablation techniques can achieve more effective ablation since it relies on active heating of the tissue using RF energy, but presently the depth of ablation using RF techniques can only be estimated by physician since no feedback can be provided as to actual ablation depth.

Both the heated fluid techniques and the latest RF techniques must be performed using great care to prevent overablation. Monitoring of tissue surface temperature is normally carried out during these ablation procedures to ensure the temperature does not exceed 100° C. If the temperature exceeds 100° C., the fluid within the tissue begins to boil and to thereby produce steam. Because ablation is carried out within a closed cavity within the body, the steam cannot escape and may instead force itself deeply into the tissue, or it may pass into areas adjacent to the area intended to be ablated, causing embolism or unintended burning.

Moreover, in prior art RF devices the water drawn from the tissue creates a path of conductivity through which current traveling through the electrodes will flow. This can prevent the current from traveling into the tissue to be ablated. Moreover, the presence of this current path around the electrodes causes current to be continuously drawn from the electrodes. The current heats the liquid drawn from the tissue and thus turns the ablation process into a passive heating method in which the heated liquid around the electrodes causes thermal ablation to continue well beyond the desired ablation depths.

Another problem with prior art ablation devices is that it is difficult for a physician to find out when ablation has been carried out to a desired depth within the tissue. Thus, it is often the case that too much or too little tissue may be ablated during an ablation procedure.

It is therefore desirable to provide an ablation device which eliminates the above-described problem of steam and liquid buildup at the ablation site. It is further desirable to provide an ablation method and device which allows the depth of ablation to be controlled and which automatically discontinues ablation once the desired ablation depth has been reached.

SUMMARY OF THE INVENTION

An apparatus and method for use in performing ablation or coagulation of organs and other tissue includes an electrode carrying member which is substantially absorbent and/or permeable to moisture and gases such as steam and conformable to the body cavity. Suctioning means may additionally be positioned within the electrode carrying member to aide the removal of moisture, and/or gas and/or liquid, present or generated during the ablation procedure. An array of electrodes is mounted to the surface of the electrode carrying member and arranged to produce ablation to a predetermined depth. The electrodes may be provided with means for variably controlling ablation depth by changing the electrode density or center to center spacing.

Following placement of the ablation device into contact with the tissue to be ablated, an RF generator is used to deliver RF energy to the electrodes and to thereby induce current flow from the electrodes to tissue to be ablated. As the current heats the tissue, moisture (such as steam or liquid) leaves the tissue causing the tissue to dehydrate. The moisture permeability and/or absorbency of the electrode carrying member allows the moisture to leave the ablation site so as to prevent the moisture from providing a path of conductivity for the current.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a front elevation view of an ablation device according to the present invention, with the handle shown in cross-section and with the RF applicator head in a closed condition.

FIG. 2 is a front elevation view of an ablation device according to the present invention, with the handle shown in cross-section and with the RF applicator head in an open condition.

FIG. 3 is a side elevation view of the ablation device of FIG. 2.

FIG. 4 is a top plan view of the ablation device of FIG. 2.

FIG. 5A is a front elevation view of the applicator head and a portion of the main body of the ablation device of FIG. 2, with the main body shown in cross-section.

FIG. 5B is a cross-section view of the main body taken along the plane designated 5B--5B in FIG. 5A.

FIG. 6 is a schematic representation of a uterus showing the ablation device of FIG. 1 following insertion of the device into the uterus but prior to retraction of the introducer sheath and activation of the spring members.

FIG. 7 is a schematic representation of a uterus showing the ablation device of FIG. 1 following insertion of the device into the uterus and following the retraction of the introducer sheath and the expansion of the RF applicator head.

FIG. 8 is a cross-section view of the RF applicator head and the distal portion of the main body of the apparatus of FIG. 1, showing the RF applicator head in the closed condition.

FIG. 9 is a cross-section view of the RF applicator head and the distal portion of the main body of the apparatus of FIG. 1, showing the configuration of RF applicator head after the sheath has been retracted but before the spring members have been released by proximal movement of the shaft. FIG. 10 is a cross-section view of the RF applicator head and the distal portion of the main body of the apparatus of FIG. 1, showing the configuration of RF applicator head after the sheath has been retracted and after the spring members have been released into the fully opened condition.

FIG. 11 is a cross-section view of an RF applicator head according to the present invention which utilizes an alternative spring member configuration.

FIG. 12 is a side elevation view of an alternate embodiment of the distal end of an ablation device according to the present invention.

FIG. 13 is a top plan view of the ablation device of FIG. 12.

FIG. 14 is a representation of a bleeding vessel illustrating use of the ablation device of FIG. 12 for general bleeding control.

FIGS. 15 and 16 are representations of a uterus illustrating use of the ablation device of FIG. 12 for endometrial ablation.

FIG. 17 is a representation of a prostate gland illustrating use of the ablation device of FIG. 12 for prostate ablation.

FIG. 18 is a cross-section view of target tissue for ablation, showing ablation electrodes in contact with the tissue surface and illustrating energy fields generated during bi-polar ablation.

FIGS. 19A-19C are cross-section views of target tissue for ablation, showing electrodes in contact with the tissue surface and illustrating how varying active electrode density may be used to vary the ablation depth.

FIG. 20 is a side elevation view, similar to the view of FIG. 2, showing an ablation device according to the present invention in which the electrode carrying means includes inflatable balloons. For purposes of clarity, the electrodes on the electrode carrying means are not shown.

DETAILED DESCRIPTION

Referring to FIGS. 1 and 2, an ablation device according to the present invention is comprised generally of three major components: RF applicator head 2, main body 4, and handle 6. Main body 4 includes a shaft 10. The RF applicator head 2 includes an electrode carrying means 12 mounted to the distal end of the shaft 10 and an array of electrodes 14 formed on the surface of the electrode carrying means 12. An RF generator 16 is electrically connected to the electrodes 14 to provide mono-polar or bipolar RF energy to them.

Shaft 10 is an elongate member having a hollow interior. Shaft 10 is preferably 12 inches long and has a preferred cross-sectional diameter of approximately 4 mm. A collar 13 is formed on the exterior of the shaft 10 at the proximal end. As best shown in FIGS. 6 and 7, passive spring member 15 are attached to the distal end of the shaft 10.

Extending through the shaft 10 is a suction/insufflation tube 17 (FIGS. 6-9) having a plurality of holes 17a formed in its distal end. An arched active spring member 19 is connected between the distal ends of the passive spring members 15 and the distal end of the suction/insufflation tube 17.

Referring to FIG. 2, electrode leads 18a and 18b extend through the shaft 10 from distal end 20 to proximal end 22 of the shaft 10. At the distal end 20 of the shaft 10, each of the leads 18a, 18b is coupled to a respective one of the electrodes 14. At the proximal end 22 of the shaft 10, the leads 18a, 18b are electrically connected to RF generator 16 via an electrical connector 21. During use, the leads 18a, 18b carry RF energy from the RF generator 16 to the electrodes. Each of the leads 18a, 18b is insulated and carries energy of an opposite polarity than the other lead.

Electrically insulated sensor leads 23a, 23b (FIGS. 5A and 5B) also extend through the shaft 10. Contact sensors 25a, 25b are attached to the distal ends of the sensor leads 23a, 23b, respectively and are mounted to the electrode carrying means 12. During use, the sensor leads 23a, 23b are coupled by the connector 21 to a monitoring module in the RF generator 16 which measures impedance between the sensors 25a, 25b. Alternatively, a reference pad may be positioned in contact with the patient and the impedance between one of the sensors and the reference pad.

Referring to FIG. 5B, electrode leads 18a, 18b and sensor leads 23a, 23b extend through the shaft 10 between the external walls of the tube 17 and the interior walls of the shaft 10 and they are coupled to electrical connector 21 which is preferably mounted to the collar 13 on the shaft 10. Connector 21, which is connectable to the RF generator 16, includes at least four electrical contact rings 21a-21d (FIGS. 1 and 2) which correspond to each of the leads 18a, 18b, 23a, 23b. Rings 21a, 21b receive, from the RF generator, RF energy of positive and negative polarity, respectively. Rings 21c, 21d deliver signals from the right and left sensors, respectively, to a monitoring module within the RF generator 16.

Referring to FIG. 5A, the electrode carrying means 12 is attached to the distal end 20 of the shaft 10. A plurality of holes 24 may be formed in the portion of the distal end 20 of the shaft which lies within the electrode carrying means 12.

The electrode carrying means 12 preferably has a shape which approximates the shape of the body organ which is to be ablated. For example, the apparatus shown in FIGS. 1 through 11 has a bicornual shape which is desirable for intrauterine ablation. The electrode carrying means 12 shown in these figures includes horn regions 26 which during use are positioned within the cornual regions of the uterus and which therefore extend towards the fallopian tubes.

Electrode carrying means 12 is preferably a sack formed of a material which is non-conductive, which is permeable to moisture and/or which has a tendency to absorb moisture, and which may be compressed to a smaller volume and subsequently released to its natural size upon elimination of compression. Examples of preferred materials for the electrode carrying means include open cell sponge, foam, cotton, fabric, or cotton-like material, or any other material having the desired characteristics. Alternatively, the electrode carrying means may be formed of a metallized fabric. For convenience, the term "pad" may be used interchangeably with the term electrode carrying means to refer to an electrode carrying means formed of any of the above materials or having the listed properties.

Electrodes 14 are preferably attached to the outer surface of the electrode carrying means 12, such as by deposition or other attachment mechanism. The electrodes are preferably made of lengths of silver, gold, platinum, or any other conductive material. The electrodes may be attached to the electrode carrying means 12 by electron beam deposition, or they may be formed into coiled wires and bonded to the electrode carrying member using a flexible adhesive. Naturally, other means of attaching the electrodes, such as sewing them onto the surface of the carrying member, may alternatively be used. If the electrode carrying means 12 is formed of a metallized fabric, an insulating layer may be etched onto the fabric surface, leaving only the electrode regions exposed.

The spacing between the electrodes (i.e. the distance between the centers of adjacent electrodes) and the widths of the electrodes are selected so that ablation will reach predetermined depths within the tissue, particularly when maximum power is delivered through the electrodes (where maximum power is the level at which low impedance, low voltage ablation can be achieved).

The depth of ablation is also effected by the electrode density (i.e., the percentage of the target tissue area which is in contact with active electrode surfaces) and may be regulated by pre-selecting the amount of this active electrode coverage. For example, the depth of ablation is much greater when the active electrode surface covers more than 10% of the target tissue than it is when the active electrode surfaces covers 1% of the target tissue.

For example, by using 3-6 mm spacing and an electrode width of approximately 0.5-2.5 mm, delivery of approximately 20-40 watts over a 9-16 cm2 target tissue area will cause ablation to a depth of approximately 5-7 millimeters when the active electrode surface covers more than 10% of the target tissue area. After reaching this ablation depth, the impedance of the tissue will become so great that ablation will self-terminate as described with respect to the operation of the invention.

By contrast, using the same power, spacing, electrode width, and RF frequency will produce an ablation depth of only 2-3 mm when the active electrode surfaces covers less than 1% of the target tissue area. This can be better understood with reference to FIG. 19A, in which high surface density electrodes are designated 14a and low surface density electrodes are designated 14b. For purposes of this comparison between low and high surface density electrodes, each bracketed group of low density electrodes is considered to be a single electrode. Thus, the electrode widths W and spacings S extend as shown in FIG. 19A.

As is apparent from FIG. 19A, the electrodes 14a, which have more active area in contact with the underlying tissue T, produce a region of ablation A1 that extends more deeply into the tissue T than the ablation region A2 produced by the low density electrodes 14b, even though the electrode spacings and widths are the same for the high and low density electrodes.

Some examples of electrode widths, having spacings with more than 10% active electrode surface coverage, and their resultant ablation depth, based on an ablation area of 6 cm2 and a power of 20-40 watts, are given on the following table:

______________________________________ELECTRODE WIDTH SPACING  APPROX. DEPTH______________________________________   1 mm         1-2 mm   1-3 mm1-2.5 mm        3-6 mm   5-7 mm1-4.5 mm        8-10 mm  8-10 mm______________________________________

Examples of electrode widths, having spacings with less than 1% active electrode surface coverage, and their resultant ablation depth, based on an ablation area of 6 cm2 and a power of 20-40 watts, are given on the following table:

______________________________________ELECTRODE WIDTH SPACING  APPROX. DEPTH______________________________________   1 mm         1-2 mm   0.5-1 mm1-2.5 mm        3-6 mm   2-3 mm1-4.5 mm        8-10 mm  2-3 mm______________________________________

Thus it can be seen that the depth of ablation is significantly less when the active electrode surface coverage is decreased.

In the preferred embodiment, the preferred electrode spacing is approximately 8-10 mm in the horn regions 26 with the active electrode surfaces covering approximately 1% of the target region. Approximately 1-2 mm electrode spacing (with 10% active electrode coverage) is preferred in the cervical region (designated 28) and approximately 3-6 mm (with greater than 10% active electrode surface coverage) is preferred in the main body region.

The RF generator 16 may be configured to include a controller which gives the user a choice of which electrodes should be energized during a particular application in order to give the user control of ablation depth. For example, during an application for which deep ablation is desired, the user may elect to have the generator energize every other electrode, to thereby optimize the effective spacing of the electrodes and to decrease the percentage of active electrode surface coverage, as will be described below with respect to FIG. 18.

Although the electrodes shown in the drawings are arranged in a particular pattern, it should be appreciated that the electrodes may be arranged in any pattern to provide ablation to desired depths.

Referring to FIGS. 6 and 7, an introducer sheath 32 facilitates insertion of the apparatus into, and removal of the apparatus from, the body organ to be ablated. The sheath 32 is a tubular member which is telescopically slidable over the shaft 10. The sheath 32 is slidable between a distal condition, shown in FIG. 6, in which the electrode carrying means 12 is compressed inside the sheath, and a proximal condition in which the sheath 32 is moved proximally to release the electrode carrying means from inside it (FIG. 7). By compressing the electrode carrying means 12 to a small volume, the electrode carrying means and electrodes can be easily inserted into the body cavity (such as into the uterus via the vaginal opening).

A handle 34 attached to the sheath 32 provides finger holds to allow for manipulation of the sheath 32. Handle 34 is slidably mounted on a handle rail 35 which includes a sleeve 33, a finger cutout 37, and a pair of spaced rails 35a, 35b extending between the sleeve 33 and the finger cutout 37. The shaft 10 and sheath 32 slidably extend through the sleeve 33 and between the rails 35a, 35b. The tube 17 also extends through the sleeve 33 and between the rails 35a, 35b, and its proximal end is fixed to the handle rail 35 near the finger cutout 37.

A compression spring 39 is disposed around the proximal most portion of the suction/insufflation tube 17 which lies between the rails 35a, 35b. One end of the compression spring 39 rests against the collar 13 on the shaft 10, while the opposite end of the compression spring rests against the handle rail 35. During use, the sheath 32 is retracted from the electrode carrying means 12 by squeezing the handle 34 towards the finger cutout 37 to slide the sheath 32 in the distal direction. When the handle 34 advances against the collar 13, the shaft 10 (which is attached to the collar 13) is forced to slide in the proximal direction, causing compression of the spring 39 against the handle rail 35. The movement of the shaft 10 relative to the suction/insufflation tube 17 causes the shaft 10 to pull proximally on the passive spring member 15. Proximal movement of the passive spring member 15 in turn pulls against the active spring member 19, causing it to move to the opened condition shown in FIG. 7. Unless the shaft is held in this retracted condition, the compression spring 39 will push the collar and thus the shaft distally, forcing the RF applicator head to close. A locking mechanism (not shown) may be provided to hold the shaft in the fully withdrawn condition to prevent inadvertent closure of the spring members during the ablation procedure.

The amount by which the springs 15, 19 are spread may be controlled by manipulating the handle 34 to slide the shaft 10 (via collar 13), proximally or distally. Such sliding movement of the shaft 10 causes forceps-like movement of the spring members 15, 19.

A flow pathway 36 is formed in the handle rail 35 and is fluidly coupled to a suction/insufflation port 38. The proximal end of the suction/insufflation tube 17 is fluidly coupled to the flow pathway so that gas fluid may be introduced into, or withdrawn from the suction/insufflation tube 17 via the suction/insufflation port 38. For example, suction may be applied to the fluid port 38 using a suction/insufflation unit 40. This causes water vapor within the uterine cavity to pass through the permeable electrode carrying means 12, into the suction/insufflation tube 17 via holes 17a, through the tube 17, and through the suction/insufflation unit 40 via the port 38. If insufflation of the uterine cavity is desired, insufflation gas, such as carbon dioxide, may be introduced into the suction/insufflation tube 17 via the port 38. The insufflation gas travels through the tube 17, through the holes 17a, and into the uterine cavity through the permeable electrode carrying member 12.

If desirable, additional components may be provided for endoscopic visualization purposes. For example, lumen 42, 44, and 46 may be formed in the walls of the introducer sheath 32 as shown in FIG. 5B. An imaging conduit, such as a fiberoptic cable 48, extends through lumen 42 and is coupled via a camera cable 43 to a camera 45. Images taken from the camera may be displayed on a monitor 56. An illumination fiber 50 extends through lumen 44 and is coupled to an illumination source 54. The third lumen 46 is an instrument channel through which surgical instruments may be introduced into the uterine cavity, if necessary.

Because during use it is most desirable for the electrodes 14 on the surface of the electrode carrying means 12 to be held in contact with the interior surface of the organ to be ablated, the electrode carrying means 12 may be provide to have additional components inside it that add structural integrity to the electrode carrying means when it is deployed within the body.

For example, referring to FIG. 11, alternative spring members 15a, 19a may be attached to the shaft 10 and biased such that, when in a resting state, the spring members are positioned in the fully resting condition shown in FIG. 11. Such spring members would spring to the resting condition upon withdrawal of the sheath 32 from the RF applicator head 2.

Alternatively, a pair of inflatable balloons 52 may be arranged inside the electrode carrying means 12 as shown in FIG. 20 and connected to a tube (not shown) extending through the shaft 10 and into the balloons 52. After insertion of the apparatus into the organ and following retraction of the sheath 32, the balloons 52 would be inflated by introduction of an inflation medium such as air into the balloons via a port similar to port 38 using an apparatus similar to the suction/insufflation apparatus 40.

Structural integrity may also be added to the electrode carrying means through the application of suction to the proximal end 22 of the suction/insufflation tube 17. Application of suction using the suction/insufflation device 40 would draw the organ tissue towards the electrode carrying means 12 and thus into better contact with the electrodes 14.

FIGS. 12 and 13 show an alternative embodiment of an ablation device according to the present invention. In the alternative embodiment, an electrode carrying means 12a is provided which has a shape which is generally tubular and thus is not specific to any particular organ shape. An ablation device having a general shape such as this may be used anywhere within the body where ablation or coagulation is needed. For example, the alternative embodiment is useful for bleeding control during laparoscopic surgery (FIG. 14), tissue ablation in the prostate gland (FIG. 17), and also intrauterine ablation (FIGS. 15 and 16).

Operation

Operation of a preferred ablation device according to the present invention will next be described.

Referring to FIG. 1, the device is initially configured for use by positioning the introducer sheath 32 distally along the shaft 10, such that it compresses the electrode carrying means 12 within its walls.

At this time, the electrical connector 21 is connected to the RF generator 16, and the fiberoptic cable 48 and the illumination cable 50 are connected to the illumination source, monitor, and camera, 54, 56, 45. The suction/insufflation unit 40 is attached to suction/insufflation port 38 on the handle rail 35. The suction/insufflation unit 40 is preferably set to deliver carbon dioxide at an insufflation pressure of 20-200 mmHg.

Next, the distal end of the apparatus is inserted through the vaginal opening V and into the uterus U as shown in FIG. 6, until the distal end of the introducer sheath 32 contacts the fundus F of the uterus. At this point, carbon dioxide gas is introduced into the tube 17 via the port 38, and it enters the uterine cavity, thereby expanding the uterine cavity from a flat triangular shape to a 1-2 cm high triangular cavity. The physician may observe (using the camera 45 and monitor 56) the internal cavities using images detected by a fiberoptic cable 48 inserted through lumen 42. If, upon observation, the physician determines that a tissue biopsy or other procedure is needed, the required instruments may be inserted into the uterine cavity via the instrument channel 46.

Following insertion, the handle 34 is withdrawn until it abuts the collar 13. At this point, the sheath 32 exposes the electrode carrying member 12 but the electrode carrying member 12 is not yet fully expanded (see FIG. 9), because the spring members 15, 19 have not yet been moved to their open condition. The handle 34 is withdrawn further, causing the shaft 10 to move proximally relative to the suction/insufflation tube 17, causing the passive spring members 15 to pull the active spring members 19, causing them to open into the opened condition shown in FIG. 10.

The physician may confirm proper positioning of the electrode carrying member 12 using the monitor 56, which displays images from the fiberoptic cable 48.

Proper positioning of the device and sufficient contact between the electrode carrying member 12 and the endometrium may further be confirmed using the contact sensors 25a, 25b. The monitoring module of the RF generator measures the impedance between these sensors using conventional means. If there is good contact between the sensors and the endometrium, the measured impedance will be approximately 20-180 ohm, depending on the water content of the endometrial lining.

The sensors are positioned on the distal portions of the bicornual shaped electrode carrying member 12, which during use are positioned in the regions within the uterus in which it is most difficult to achieve good contact with the endometrium. Thus, an indication from the sensors 25a, 25b that there is sound contact between the sensors and the endometrial surface indicates that good electrode contact has been made with the endometrium.

Next, insufflation is terminated. Approximately 1-5 cc of saline may be introduced via suction/insufflation tube 17 to initially wet the electrodes and to improve electrode electrical contact with the tissue. After introduction of saline, the suction/insufflation device 40 is switched to a suctioning mode. As described above, the application of suction to the RF applicator head 2 via the suction/insufflation tube 17 collapses the uterine cavity onto the RF applicator head 2 and thus assures better contact between the electrodes and the endometrial tissue.

If the generally tubular apparatus of FIGS. 12 and 13 is used, the device is angled into contact with one side of the uterus during the ablation procedure. Once ablation is completed, the device (or a new device) is repositioned in contact with the opposite side and the procedure is repeated. See FIGS. 15 and 16.

Next, RF energy at preferably about 500 kHz and at a constant power of approximately 30 W is applied to the electrodes. As shown in FIG. 5a, it is preferable that each electrode be energized at a polarity opposite from that of its neighboring electrodes. By doing so, energy field patterns, designated 100, 102 and 104 in FIG. 18, are generated between the electrode sites and thus help to direct the flow of current through the tissue T to form a region of ablation A. As can be seen in FIG. 18, if electrode spacing is increased such by energizing, for example every third or fifth electrode rather than all electrodes, the energy patterns will extend more deeply into the tissue. (See, for example, pattern 102 which results from energization of electrodes having a non-energized electrode between them, or pattern 104 which results from energization of electrodes having two non-energized electrodes between them).

Moreover, ablation depth may be controlled as described above by providing low surface density electrodes on areas of the electrode carrying member which will contact tissue areas at which a smaller ablation depth is required (see FIG. 19A).

Referring to FIG. 19B, if multiple, closely spaced, electrodes 14 are provided on the electrode carrying member, a user may set the RF generator to energize electrodes which will produce a desired electrode spacing and active electrode area. For example, alternate electrodes may be energized as shown in FIG. 19B, with the first three energized electrodes having positive polarity, the second three having negative polarity, etc.

As another example, shown in FIG. 19C, if greater ablation depth is desired the first five electrodes may be positively energized, and the seventh through eleventh electrodes negatively energized, with the sixth electrode remaining inactivated to provide adequate electrode spacing.

As the endometrial tissue heats, moisture begins to be released from the tissue. The moisture permeates the electrode carrying member 12 and is thereby drawn away from the electrodes. The moisture may pass through the holes 17a in the suction/insufflation tube 17 and leave the suction/insufflation tube 17 at its proximal end via port 38 as shown in FIG. 7. Moisture removal from the ablation site may be further facilitated by the application of suction to the shaft 10 using the suction/insufflation unit 40.

Removal of the moisture from the ablation site prevents formation of a liquid layer around the electrodes. As described above, liquid build-up at the ablation site is detrimental in that provides a conductive layer that carries current from the electrodes even when ablation has reached the desired depth. This continued current flow heats the liquid and surrounding tissue, and thus causes ablation to continue by unpredictable thermal conduction means.

Tissue which has been ablated becomes dehydrated and thus decreases in conductivity. By shunting moisture away from the ablation site and thus preventing liquid build-up, there is no liquid conductor at the ablation area during use of the ablation device of the present invention. Thus, when ablation has reached the desired depth, the impedance at the tissue surface becomes sufficiently high to stop or nearly stop the flow of current into the tissue. RF ablation thereby stops and thermal ablation does not occur in significant amounts. If the RF generator is equipped with an impedance monitor, a physician utilizing the ablation device can monitor the impedance at the electrodes and will know that ablation has self-terminated once the impedance rises to a certain level and then remains fairly constant. By contrast, if a prior art bipolar RF ablation device was used together with an impedance monitor, the presence of liquid around the electrodes would cause the impedance monitor to gives a low impedance reading regardless of the depth of ablation which had already been carried out, since current would continue to travel through the low-impedance liquid layer.

Other means for monitoring and terminating ablation may also be provided. For example, a thermocouple or other temperature sensor may be inserted to a predetermined depth in the tissue to monitor the temperature of the tissue and terminate the delivery of RF energy or otherwise signal the user when the tissue has reached a desired ablation temperature.

Once the process has self terminated, 1-5 cc of saline can be introduced via suction/insufflation tube 17 and allowed to sit for a short time to aid separation of the electrode from the tissue surface. The suction/insufflation device 40 is then switched to provide insufflation of carbon dioxide at a pressure of 20-200 mmHg. The insufflation pressure helps to lift the ablated tissue away from the RF applicator head 2 and to thus ease the closing of the RF applicator head. The RF applicator head 2 is moved to the closed position by sliding the handle 34 in a distal direction to fold the spring members 15, 19 along the axis of the device and to cause the introducer sheath 32 to slide over the folded RF applicator head. The physician may visually confirm the sufficiency of the ablation using the monitor 56. Finally, the apparatus is removed from the uterine cavity.

Patentzitate
Zitiertes PatentEingetragen Veröffentlichungsdatum Antragsteller Titel
US1620929 *5. Febr. 192515. März 1927Wallerich George WHeat-therapy method and means
US1827306 *14. Sept. 192513. Okt. 1931Fischer & Co H GElectrode
US2190383 *29. Aug. 193613. Febr. 1940Newman Louis BTherapeutic apparatus
US2466042 *26. Aug. 19475. Apr. 1949Nechtow Mitchell JInternal heat-treatment device
US3645265 *25. Juni 196929. Febr. 1972Majzlin GregoryIntrauterine cauterizing device
US3840016 *7. März 19738. Okt. 1974Lindemann HElectrocoagulation-bougie for the intrauterine tube sterilization
US3924628 *1. Dez. 19729. Dez. 1975Paul E BinghamCyrogenic bladder for necrosing tissue cells
US3948270 *15. Okt. 19746. Apr. 1976Hasson Harrith MUterine cannula
US4057063 *27. Febr. 19768. Nov. 1977U.S. Philips CorporationDevice for sterilization by transuterine tube coagulation
US4449528 *20. Juli 198122. Mai 1984University Of WashingtonFast pulse thermal cautery probe and method
US4492231 *17. Sept. 19828. Jan. 1985Auth David CNon-sticking electrocautery system and forceps
US4532924 *30. Apr. 19826. Aug. 1985American Hospital Supply CorporationMultipolar electrosurgical device and method
US4582057 *21. Nov. 198315. Apr. 1986Regents Of The University Of WashingtonFast pulse thermal cautery probe
US4601698 *17. Sept. 198422. Juli 1986Moulding Jr Thomas SMethod of and instrument for injecting a fluid into a uterine cavity and for dispersing the fluid into the fallopian tubes
US4662383 *23. Sept. 19835. Mai 1987Kureha Kagaku Kogyo Kabushiki KaishaEndotract antenna device for hyperthermia
US4676258 *5. Juni 198630. Juni 1987Kureha Kagaku Kogyo Kabushiki KaishaDevice for hyperthermia
US4691703 *25. Apr. 19868. Sept. 1987Board Of Regents, University Of WashingtonThermal cautery system
US4832048 *29. Okt. 198723. Mai 1989Cordis CorporationSuction ablation catheter
US4865047 *30. Juni 198812. Sept. 1989City Of HopeHyperthermia applicator
US4949718 *9. Sept. 198821. Aug. 1990Gynelab ProductsIntrauterine cauterizing apparatus
US4960133 *21. Nov. 19882. Okt. 1990Brunswick Manufacturing Co., Inc.Esophageal electrode
US4961435 *17. Okt. 19889. Okt. 1990Kureha Kagaku Kogyo Kabushiki KaishiHigh-frequency capacitive heating electrode device
US4979948 *13. Apr. 198925. Dez. 1990Purdue Research FoundationMethod and apparatus for thermally destroying a layer of an organ
US5057106 *9. Juli 199015. Okt. 1991Kasevich Associates, Inc.Microwave balloon angioplasty
US5084044 *14. Juli 198928. Jan. 1992Ciron CorporationApparatus for endometrial ablation and method of using same
US5105808 *9. Aug. 199021. Apr. 1992Gynelab ProductsIntrauterine cauterizing method
US5147353 *23. März 199015. Sept. 1992Myriadlase, Inc.Medical method for applying high energy light and heat for gynecological sterilization procedures
US5159925 *28. Jan. 19913. Nov. 1992Gynelab, Inc.Cauterizing apparatus and method for laparoscopic cholecystostomy, gallbladder ablation and treatment of benign prostate hypertrophy
US5186181 *27. Juli 199016. Febr. 1993Cafiero FranconiRadio frequency thermotherapy
US5188122 *20. Juni 199023. Febr. 1993Rocket Of London LimitedElectromagnetic energy generation method
US5188602 *8. Juni 199223. Febr. 1993Interventional Thermodynamics, Inc.Method and device for delivering heat to hollow body organs
US5227201 *20. Juni 199113. Juli 1993E. I. Du Pont De Nemours And CompanyLow voc clear coating composition for basecoat clear coat finish
US5248312 *1. Juni 199228. Sept. 1993Sensor Electronics, Inc.Liquid metal-filled balloon
US5308327 *25. Nov. 19913. Mai 1994Advanced Surgical Inc.Self-deployed inflatable retractor
US5334193 *13. Nov. 19922. Aug. 1994American Cardiac Ablation Co., Inc.Fluid cooled ablation catheter
US5364393 *30. Dez. 199315. Nov. 1994Heart Technology, Inc.Tissue dissipative recanalization catheter
US5433708 *7. Juni 199318. Juli 1995Innerdyne, Inc.Method and device for thermal ablation having improved heat transfer
US5437629 *14. Apr. 19941. Aug. 1995Bei Medical SystemsFluid delivery system for hysteroscopic endometrial ablation
US5443470 *14. Apr. 199322. Aug. 1995Vesta Medical, Inc.Method and apparatus for endometrial ablation
US5505730 *24. Juni 19949. Apr. 1996Stuart D. EdwardsThin layer ablation apparatus
EP0584930A1 *20. Juli 19932. März 1994Spembly Medical LimitedCryosurgical ablation
WO1992019145A2 *4. Mai 199212. Nov. 1992Goldrath Milton HEndometrium coagulating apparatus and surgical method for thermal destruction of the endometrium
WO1994007445A1 *30. Sept. 199314. Apr. 1994Neuwirth Robert SHeated balloon medical apparatus with fluid agitating means
WO1994010948A1 *10. Nov. 199326. Mai 1994Neuwirth Robert SHeated balloon medical apparatus
WO1994023794A1 *11. Apr. 199427. Okt. 1994Vesta Medical, Inc.Method and apparatus for endometrial ablation
WO1995004385A1 *19. Juli 19949. Febr. 1995Microsulis LimitedTreatment apparatus
WO1995005869A1 *24. Aug. 19942. März 1995Kaare GrueA probe for a microwave apparatus for clinical and surgical treatment
WO1995007664A1 *13. Sept. 199423. März 1995Origin Medsystems, Inc.Apparatus and method for organ ablation
WO1995010326A1 *14. Okt. 199420. Apr. 1995Vesta Medical, Inc.Bipolar/monopolar endometrial ablation device and method
Referenziert von
Zitiert von PatentEingetragen Veröffentlichungsdatum Antragsteller Titel
US5895417 *6. Nov. 199720. Apr. 1999Cardiac Pathways CorporationDeflectable loop design for a linear lesion ablation apparatus
US6029091 *9. Juli 199822. Febr. 2000Irvine Biomedical, Inc.Catheter system having lattice electrodes
US6032077 *3. Juli 199729. Febr. 2000Cardiac Pathways CorporationAblation catheter with electrical coupling via foam drenched with a conductive fluid
US6119041 *4. Aug. 199812. Sept. 2000Cardiac Pathways CorporationApparatus and method for linear lesion ablation
US6139538 *6. Okt. 199731. Okt. 2000Iotek, Inc.Iontophoretic agent delivery to the female reproductive tract
US6156060 *13. Okt. 19985. Dez. 2000Surx, Inc.Static devices and methods to shrink tissues for incontinence
US6176856 *18. Dez. 199823. Jan. 2001Eclipse Surgical Technologies, IncResistive heating system and apparatus for improving blood flow in the heart
US623689113. Okt. 199822. Mai 2001Surx, Inc.Limited heat transfer devices and methods to shrink tissues
US626465324. Sept. 199924. Juli 2001C. R. Band, Inc.System and method for gauging the amount of electrode-tissue contact using pulsed radio frequency energy
US6283962 *7. Dez. 19994. Sept. 2001Quantum Therapeutics Corp.Device for valvular annulus treatment and methods thereof
US632258413. Okt. 199827. Nov. 2001Surx, Inc.Temperature sensing devices and methods to shrink tissues
US6425877 *6. Mai 199930. Juli 2002Novasys Medical, Inc.Treatment of tissue in the digestive circulatory respiratory urinary and reproductive systems
US64684626. Mai 200022. Okt. 2002Ams Research CorporationMethod for making an electrode balloon
US648074613. Aug. 199712. Nov. 2002Surx, Inc.Noninvasive devices, methods, and systems for shrinking of tissues
US6488679 *26. Juli 20003. Dez. 2002Scimed Life Systems, Inc.Systems and methods for controlling power in an electrosurgical probe
US649488026. Juli 200017. Dez. 2002Scimed Life Systems, Inc.Systems and methods for controlling power in an electrosurgical probe
US652977516. Jan. 20014. März 2003Alsius CorporationSystem and method employing indwelling RF catheter for systemic patient warming by application of dielectric heating
US654693430. Aug. 200015. Apr. 2003Surx, Inc.Noninvasive devices and methods for shrinking of tissues
US6554780 *10. Nov. 200029. Apr. 2003NovaceptSystem and method for detecting perforations in a body cavity
US655838119. Jan. 20016. Mai 2003Surx, Inc.Noninvasive devices, methods, and systems for shrinking of tissues
US662953523. Jan. 20017. Okt. 2003Surx, Inc.Noninvasive devices, methods, and systems for shrinking of tissues
US674318427. März 20031. Juni 2004NovaceptSystem and method for detecting perforations in a body cavity
US67515079. Juli 200115. Juni 2004Solarant Medical, Inc.Endopelvic fascia treatment for incontinence
US6758847 *6. Juni 20026. Juli 2004Atrionix, Inc.Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US677677930. Aug. 200017. Aug. 2004Solarant Medical, Inc.Static devices and methods to shrink tissues for incontinence
US679363528. Juni 200221. Sept. 2004Ethicon, Inc.Devices having deployable ultrasound transducers and method of use of same
US687218324. Mai 200429. März 2005Cytyc Surgical ProductSystem and method for detecting perforations in a body cavity
US688121323. Okt. 200219. Apr. 2005Ethicon, Inc.Device and method to expand treatment array
US6887237 *22. Juli 20023. Mai 2005Medtronic, Inc.Method for treating tissue with a wet electrode and apparatus for using same
US692964223. Okt. 200216. Aug. 2005Ethicon, Inc.RF device for treating the uterus
US69764927. Jan. 200320. Dez. 2005Solarant Medical, Inc.Noninvasive devices, methods, and systems for shrinking of tissues
US700494010. Okt. 200228. Febr. 2006Ethicon, Inc.Devices for performing thermal ablation having movable ultrasound transducers
US70084209. Dez. 20037. März 2006Olympus CorporationHigh frequency surgical instrument
US706367011. Febr. 200520. Juni 2006Cytyc Surgical ProductsSystem and method for detecting perforations in a body cavity
US70870521. Okt. 20038. Aug. 2006Cytyc Surgical ProductsApparatus and method for treating venous reflux
US710136730. Sept. 20025. Sept. 2006Ethicon, Inc.Deployable cryosurgical catheter
US71507459. Jan. 200419. Dez. 2006Barrx Medical, Inc.Devices and methods for treatment of luminal tissue
US72941265. Jan. 200413. Nov. 2007Cytyc CorporationApparatus and method for treating venous reflux
US731794919. Apr. 20048. Jan. 2008Ams Research CorporationEnergy induced bulking and buttressing of tissues for incontinence
US74702717. Juli 200430. Dez. 2008Ams Research CorporationStatic devices and methods to shrink tissues for incontinence
US7476242 *30. Jan. 200413. Jan. 2009Ams Research CorporationElectrically heated/phase change probe temperature control
US75124453. Aug. 200531. März 2009Cytyc CorporationMoisture transport system for contact electrocoagulation
US753097919. Febr. 200312. Mai 2009BÂRRX Medical, Inc.Method of treating abnormal tissue in the human esophagus
US758208422. Nov. 20021. Sept. 2009Boston Scientific Scimed, Inc.Systems and methods for controlling power in an electrosurgical probe
US76046336. Okt. 200420. Okt. 2009Cytyc CorporationMoisture transport system for contact electrocoagulation
US767426028. Apr. 20059. März 2010Cytyc CorporationEmergency hemostasis device utilizing energy
US7717909 *24. Aug. 200518. Mai 2010Cytyc Surgical ProductsRadio-frequency generator for powering an ablation device
US773171220. Dez. 20048. Juni 2010Cytyc CorporationMethod and system for transcervical tubal occlusion
US773636215. Sept. 200315. Juni 2010Boston Scientific Scimed, Inc.Catheter balloons
US781557120. Apr. 200619. Okt. 2010Gynesonics, Inc.Rigid delivery systems having inclined ultrasound and needle
US784616021. Dez. 20067. Dez. 2010Cytyc CorporationMethod and apparatus for sterilization
US787498628. Nov. 200625. Jan. 2011Gynesonics, Inc.Methods and devices for visualization and ablation of tissue
US79187952. Febr. 20065. Apr. 2011Gynesonics, Inc.Method and device for uterine fibroid treatment
US795962723. Nov. 200514. Juni 2011Barrx Medical, Inc.Precision ablating device
US79933364. Dez. 20069. Aug. 2011Barrx Medical, Inc.Methods and systems for determining physiologic characteristics for treatment of the esophagus
US799727823. Nov. 200516. Aug. 2011Barrx Medical, Inc.Precision ablating method
US801214925. Mai 20106. Sept. 2011Barrx Medical, Inc.Methods and systems for determining physiologic characteristics for treatment of the esophagus
US80880723. Okt. 20083. Jan. 2012Gynesonics, Inc.Methods and systems for controlled deployment of needles in tissue
US81630319. Nov. 201024. Apr. 2012Dfine, Inc.Composites and methods for treating bone
US819242618. Dez. 20075. Juni 2012Tyco Healthcare Group LpDevices and methods for treatment of luminal tissue
US819747022. Aug. 200812. Juni 2012Aegea Medical, Inc.Uterine therapy device and method
US819747626. Okt. 201112. Juni 2012Hermes Innovations LlcTissue ablation systems
US819747726. Okt. 201112. Juni 2012Hermes Innovations LlcTissue ablation methods
US82063008. Febr. 201126. Juni 2012Gynesonics, Inc.Ablation device with articulated imaging transducer
US821621722. Aug. 200810. Juli 2012Aegea Medical, Inc.Uterine therapy device and method
US822140122. Aug. 200817. Juli 2012Aegea Medical, Inc.Uterine therapy device and method
US822140322. Aug. 200817. Juli 2012Aegea Medical, Inc.Uterine therapy device and method
US82519923. Juli 200828. Aug. 2012Tyco Healthcare Group LpMethod and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight-loss operation
US826257425. Febr. 201011. Sept. 2012Gynesonics, Inc.Needle and tine deployment mechanism
US826257730. Nov. 201111. Sept. 2012Gynesonics, Inc.Methods and systems for controlled deployment of needles in tissue
US827301230. Juli 200725. Sept. 2012Tyco Healthcare Group, LpCleaning device and methods
US8277445 *8. März 20102. Okt. 2012Cytyc CorporationAblation device
US834307811. Nov. 20091. Jan. 2013Minerva Surgical, Inc.Methods for evaluating the integrity of a uterine cavity
US8347891 *14. Nov. 20068. Jan. 2013Medtronic Ardian Luxembourg S.A.R.L.Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US837206813. Aug. 200912. Febr. 2013Hermes Innovations, LLCTissue ablation systems
US837705525. Juli 201119. Febr. 2013Covidien LpMethods and systems for determining physiologic characteristics for treatment of the esophagus
US838275313. Aug. 200926. Febr. 2013Hermes Innovations, LLCTissue ablation methods
US839403711. Nov. 200912. März 2013Minerva Surgical, Inc.Systems and devices for evaluating the integrity of a uterine cavity
US839863127. Okt. 200819. März 2013Covidien LpSystem and method of treating abnormal tissue in the human esophagus
US84399083. Juli 200814. Mai 2013Covidien LpAblation in the gastrointestinal tract to achieve hemostasis and eradicate lesions with a propensity for bleeding
US848606018. Sept. 200616. Juli 2013Cytyc CorporationPower ramping during RF ablation
US848702127. Febr. 200916. Juli 2013Dfine, Inc.Bone treatment systems and methods
US850073226. Okt. 20096. Aug. 2013Hermes Innovations LlcEndometrial ablation devices and systems
US850648520. Dez. 201013. Aug. 2013Gynesonics, IncDevices and methods for treatment of tissue
US850656319. Okt. 200913. Aug. 2013Cytyc Surgical ProductsMoisture transport system for contact electrocoagulation
US8523856 *5. Sept. 20123. Sept. 2013Cytyc CorporationHemostasis device
US852956213. Nov. 200910. Sept. 2013Minerva Surgical, IncSystems and methods for endometrial ablation
US854070826. Okt. 200924. Sept. 2013Hermes Innovations LlcEndometrial ablation method
US855108219. März 20128. Okt. 2013Cytyc Surgical ProductsRadio-frequency generator for powering an ablation device
US859728929. Jan. 20103. Dez. 2013Cytyc CorporationCervical opening sealing devices
US86417112. Mai 20084. Febr. 2014Covidien LpMethod and apparatus for gastrointestinal tract ablation for treatment of obesity
US864646030. Juli 200711. Febr. 2014Covidien LpCleaning device and methods
US86908739. Juli 20138. Apr. 2014Hermes Innovations LlcEndometrial ablation devices and systems
US870269420. Dez. 200522. Apr. 2014Covidien LpAuto-aligning ablating device and method of use
US870269513. März 200922. Apr. 2014Covidien LpAuto-aligning ablating device and method of use
US871527811. Nov. 20096. Mai 2014Minerva Surgical, Inc.System for endometrial ablation utilizing radio frequency
US87252498. März 201213. Mai 2014Nephera Ltd.Stimulation of the urinary system
US874084617. Dez. 20123. Juni 2014Verathon, Inc.Treatment of tissue in sphincters, sinuses, and orifices
US877126322. Jan. 20098. Juli 2014Syneron Medical LtdDevice, apparatus, and method of adipose tissue treatment
US877800320. Aug. 200915. Juli 2014Syneron Medical LtdMethod and apparatus for personal skin treatment
US878433820. Juni 200822. Juli 2014Covidien LpElectrical means to normalize ablational energy transmission to a luminal tissue surface of varying size
US880828121. Okt. 200919. Aug. 2014Microcube, LlcMicrowave treatment devices and methods
US881479610. Jan. 201226. Aug. 2014Hologic, Inc.System and method for tissue ablation in a body cavity
US882148611. Nov. 20102. Sept. 2014Hermes Innovations, LLCTissue ablation systems and methods
US887681814. Jan. 20134. Nov. 2014Covidien LpMethods and systems for determining physiologic characteristics for treatment of the esophagus
US888018525. Juni 20134. Nov. 2014Boston Scientific Scimed, Inc.Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US8892206 *23. Okt. 200718. Nov. 2014Advanced Neuromodulation Systems, Inc.Closed-loop deep brain stimulation system adapted to accommodate glial scarring and method of operation
US89002319. Febr. 20102. Dez. 2014Syneron Medical LtdMethod and system for invasive skin treatment
US890601515. Febr. 20119. Dez. 2014Syneron Medical, LtdMethod and system for invasive skin treatment
US89239709. Juni 201130. Dez. 2014Nephera Ltd.Stimulation of the urinary system
US892662911. Okt. 20116. Jan. 2015Minerva Surgical, Inc.Systems and methods for endometrial ablation
US893659330. Sept. 201320. Jan. 2015Syneron Medical Ltd.Device, apparatus, and method of adipose tissue treatment
US893997029. Febr. 201227. Jan. 2015Vessix Vascular, Inc.Tuned RF energy and electrical tissue characterization for selective treatment of target tissues
US89399719. März 201227. Jan. 2015Minerva Surgical, Inc.System and method for endometrial ablation
US89512517. Nov. 201210. Febr. 2015Boston Scientific Scimed, Inc.Ostial renal nerve ablation
US895634820. Juli 201117. Febr. 2015Minerva Surgical, Inc.Methods and systems for endometrial ablation
US896828414. Juni 20133. März 2015Verathon Inc.Apparatus and methods for treating female urinary incontinence
US896828721. Okt. 20093. März 2015Microcube, LlcMethods and devices for applying energy to bodily tissues
US897445125. Okt. 201110. März 2015Boston Scientific Scimed, Inc.Renal nerve ablation using conductive fluid jet and RF energy
US899889815. Mai 20147. Apr. 2015Cytyc Surgical ProductsMoisture transport system for contact electrocoagulation
US899890123. Aug. 20137. Apr. 2015Hermes Innovations LlcEndometrial ablation method
US902303129. Apr. 20095. Mai 2015Verathon Inc.Noninvasive devices, methods, and systems for modifying tissues
US902303422. Nov. 20115. Mai 2015Boston Scientific Scimed, Inc.Renal ablation electrode with force-activatable conduction apparatus
US902847221. Dez. 201212. Mai 2015Vessix Vascular, Inc.Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US902848523. Sept. 201112. Mai 2015Boston Scientific Scimed, Inc.Self-expanding cooling electrode for renal nerve ablation
US903725921. Dez. 201219. Mai 2015Vessix Vascular, Inc.Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US903969912. Juli 201126. Mai 2015Covidien LpMethods and systems for treatment of tissue in a body lumen
US905010214. März 20129. Juni 2015Minerva Surgical Inc.System and method for endometrial ablation
US905010322. März 20129. Juni 2015Minerva Surgical Inc.System and method for endometrial ablation
US905010621. Dez. 20129. Juni 2015Boston Scientific Scimed, Inc.Off-wall electrode device and methods for nerve modulation
US90607619. Nov. 201123. Juni 2015Boston Scientific Scime, Inc.Catheter-focused magnetic field induced renal nerve ablation
US907290221. Dez. 20127. Juli 2015Vessix Vascular, Inc.Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US907900016. Okt. 201214. Juli 2015Boston Scientific Scimed, Inc.Integrated crossing balloon catheter
US90845874. Juni 201221. Juli 2015Syneron Medical LtdMethod and apparatus for personal skin treatment
US908460918. Juli 201121. Juli 2015Boston Scientific Scime, Inc.Spiral balloon catheter for renal nerve ablation
US90893509. Nov. 201128. Juli 2015Boston Scientific Scimed, Inc.Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9095348 *8. Aug. 20134. Aug. 2015Cytyc Surgical ProductsMoisture transport system for contact electrocoagulation
US911960015. Nov. 20121. Sept. 2015Boston Scientific Scimed, Inc.Device and methods for renal nerve modulation monitoring
US911963216. Nov. 20121. Sept. 2015Boston Scientific Scimed, Inc.Deflectable renal nerve ablation catheter
US912566628. Sept. 20078. Sept. 2015Vessix Vascular, Inc.Selectable eccentric remodeling and/or ablation of atherosclerotic material
US912566718. Okt. 20078. Sept. 2015Vessix Vascular, Inc.System for inducing desirable temperature effects on body tissue
US915558922. Juli 201113. Okt. 2015Boston Scientific Scimed, Inc.Sequential activation RF electrode set for renal nerve ablation
US916204628. Sept. 201220. Okt. 2015Boston Scientific Scimed, Inc.Deflectable medical devices
US917369617. Sept. 20133. Nov. 2015Boston Scientific Scimed, Inc.Self-positioning electrode system and method for renal nerve modulation
US917405021. Dez. 20123. Nov. 2015Vessix Vascular, Inc.Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US917997012. Juli 201110. Nov. 2015Covidien LpPrecision ablating method
US91862082. Nov. 201217. Nov. 2015Minerva Surgical, Inc.Systems for endometrial ablation
US918620920. Juli 201217. Nov. 2015Boston Scientific Scimed, Inc.Nerve modulation system having helical guide
US918621010. Okt. 201217. Nov. 2015Boston Scientific Scimed, Inc.Medical devices including ablation electrodes
US918621125. Jan. 201317. Nov. 2015Boston Scientific Scimed, Inc.Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US919243522. Nov. 201124. Nov. 2015Boston Scientific Scimed, Inc.Renal denervation catheter with cooled RF electrode
US919279013. Apr. 201124. Nov. 2015Boston Scientific Scimed, Inc.Focused ultrasonic renal denervation
US91987139. Juni 20141. Dez. 2015Covidien LpElectrical means to normalize ablational energy transmission to a luminal tissue surface of varying size
US921619519. Juni 201322. Dez. 2015Dfine, Inc.Bone treatment systems and methods
US922055826. Okt. 201129. Dez. 2015Boston Scientific Scimed, Inc.RF renal denervation catheter with multiple independent electrodes
US922056119. Jan. 201229. Dez. 2015Boston Scientific Scimed, Inc.Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
US92479892. März 20152. Febr. 2016Cytyc Surgical ProductsMoisture transport system for contact electrocoagulation
US92592624. Nov. 201116. Febr. 2016Minerva Surgical, Inc.Systems and methods for endometrial ablation
US926556322. Febr. 200723. Febr. 2016Custom Medical Applications, Inc.Ablation instruments and related methods
US926596910. Dez. 201223. Febr. 2016Cardiac Pacemakers, Inc.Methods for modulating cell function
US927179313. Sept. 20131. März 2016Syneron Medical Ltd.Method and apparatus for personal skin treatment
US927795210. Okt. 20148. März 2016Channel Medsystems, Inc.Cryogenic treatment systems
US927795511. Apr. 20118. März 2016Vessix Vascular, Inc.Power generating and control apparatus for the treatment of tissue
US927823022. Febr. 20108. März 2016Syneron Medical LtdElectrical skin rejuvenation
US928302230. Jan. 201215. März 2016Channel Medsystems, Inc.Methods and apparatus for cryogenic treatment of a body cavity or lumen
US928925713. Nov. 200922. März 2016Minerva Surgical, Inc.Methods and systems for endometrial ablation utilizing radio frequency
US929585815. Juli 200929. März 2016Syneron Medical, LtdApplicator for skin treatment with automatic regulation of skin protrusion magnitude
US92978454. März 201429. März 2016Boston Scientific Scimed, Inc.Medical devices and methods for treatment of hypertension that utilize impedance compensation
US93015884. Nov. 20135. Apr. 2016Syneron Medical LtdHair removal apparatus for personal use and the method of using same
US931428922. Aug. 201219. Apr. 2016Covidien LpCleaning device and methods
US931429312. März 200919. Apr. 2016Syneron Medical LtdRF electrode for aesthetic and body shaping devices and method of using same
US932675114. Nov. 20113. Mai 2016Boston Scientific Scimed, Inc.Catheter guidance of external energy for renal denervation
US932710012. März 20133. Mai 2016Vessix Vascular, Inc.Selective drug delivery in a lumen
US93331114. Febr. 201310. Mai 2016Hologic, Inc.Fundus bumper mechanical reference for easier mechanism deployment
US93393306. Mai 201517. Mai 2016Minerva Surgical, Inc.System and method for endometrial ablation
US93579775. Jan. 20077. Juni 2016Gynesonics, Inc.Interventional deployment and imaging system
US935836530. Juli 20117. Juni 2016Boston Scientific Scimed, Inc.Precision electrode movement control for renal nerve ablation
US936428326. Juli 201214. Juni 2016Covidien LpMethod and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight loss operation
US936428410. Okt. 201214. Juni 2016Boston Scientific Scimed, Inc.Method of making an off-wall spacer cage
US93930693. Mai 201219. Juli 2016Covidien LpDevices and methods for treatment of luminal tissue
US94026846. Febr. 20132. Aug. 2016Boston Scientific Scimed, Inc.Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US940865721. Nov. 20139. Aug. 2016Channel Medsystems, Inc.Cryogenic treatment systems
US940866118. Juli 20119. Aug. 2016Patrick A. HaverkostRF electrodes on multiple flexible wires for renal nerve ablation
US94209558. Okt. 201223. Aug. 2016Boston Scientific Scimed, Inc.Intravascular temperature monitoring system and method
US942105926. Apr. 201123. Aug. 2016Minerva Surgical, Inc.Device for endometrial ablation having an expandable seal for a cervical canal
US94334578. März 20106. Sept. 2016Tsunami Medtech, LlcMedical instruments and techniques for thermally-mediated therapies
US943376011. Dez. 20126. Sept. 2016Boston Scientific Scimed, Inc.Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US944585427. Febr. 200920. Sept. 2016Dfine, Inc.Bone treatment systems and methods
US9445860 *6. Sept. 201320. Sept. 2016Channel Medsystems, Inc.Handheld cyrogenic treatment systems
US946306222. Juli 201111. Okt. 2016Boston Scientific Scimed, Inc.Cooled conductive balloon RF catheter for renal nerve ablation
US946848729. Apr. 201318. Okt. 2016Tsunami Medtech, LlcMedical instrument and method of use
US94862194. Apr. 20128. Nov. 2016Treus Medical, Inc.Biliary shunts, delivery systems, methods of using the same and kits therefor
US9486267 *23. Mai 20138. Nov. 2016Channel Medsystems, Inc.Cryogenic treatment systems
US94863557. Jan. 20138. Nov. 2016Vessix Vascular, Inc.Selective accumulation of energy with or without knowledge of tissue topography
US94922176. Sept. 201315. Nov. 2016Channel Medsystems, Inc.Treatments using cryogenic ablation systems
US94922186. Sept. 201315. Nov. 2016Channel Medsystems, Inc.Pressure monitoring systems
US94982746. Sept. 201322. Nov. 2016Channel Medsystems, Inc.Liner extraction methods
US949862420. Nov. 201422. Nov. 2016Nephera Ltd.Stimulation of the urinary system
US95048266. Juli 201129. Nov. 2016Syneron Medical LtdSkin treatment apparatus for personal use and method for using same
US95108876. Sept. 20136. Dez. 2016Channel Medsystems, Inc.Time-limited methods for cryogenic treatment systems
US951089726. Okt. 20116. Dez. 2016Hermes Innovations LlcRF-electrode surface and method of fabrication
US95109017. Nov. 20126. Dez. 2016Vessix Vascular, Inc.Selectable eccentric remodeling and/or ablation
US951704710. Mai 201613. Dez. 2016Gynesonics, Inc.Interventional deployment and imaging system
US95171006. Sept. 201313. Dez. 2016Channel Medsystems, Inc.Cryogenic treatment methods
US9550014 *15. März 201224. Jan. 2017Inpress Technologies, Inc.Postpartum uterine contractile apparatus and method
US95548534. Okt. 201331. Jan. 2017Hologic, Inc.Radio-frequency generator for powering an ablation device
US95552221. Okt. 201431. Jan. 2017Covidien LpMethods and systems for determining physiologic characteristics for treatment of the esophagus
US95610661. Juni 20127. Febr. 2017Virender K. SharmaMethod and apparatus for tissue ablation
US956106717. Jan. 20147. Febr. 2017Virender K. SharmaMethod and apparatus for tissue ablation
US956106812. Jan. 20157. Febr. 2017Virender K. SharmaMethod and apparatus for tissue ablation
US957903020. Juli 201228. Febr. 2017Boston Scientific Scimed, Inc.Percutaneous devices and methods to visualize, target and ablate nerves
US95857124. Dez. 20147. März 2017Minerva Surgical, Inc.Systems and methods for endometrial ablation
US959238621. Dez. 201214. März 2017Vessix Vascular, Inc.Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US959714721. Apr. 201521. März 2017Covidien LpMethods and systems for treatment of tissue in a body lumen
US96036507. März 201628. März 2017Channel Medsystems, Inc.Cryogenic treatment systems
US9615875 *17. März 201411. Apr. 2017Tsunami Med Tech, LLCMedical instruments and techniques for thermally-mediated therapies
US96158822. März 201511. Apr. 2017Microcube, LlcMethods and devices for applying energy to bodily tissues
US963617119. Febr. 20162. Mai 2017Minerva Surgical, Inc.Methods and systems for endometrial ablation utilizing radio frequency
US9636495 *27. Jan. 20092. Mai 2017Oncother Kft.Flexible and porous large-area electrode for heating
US96491257. Okt. 201416. Mai 2017Hermes Innovations LlcLaparoscopic device
US964915612. Febr. 201516. Mai 2017Boston Scientific Scimed, Inc.Bipolar off-wall electrode device for renal nerve ablation
US965555730. Jan. 201223. Mai 2017Minerva Surgical, Inc.Methods and systems for evaluating the integrity of a uterine cavity
US9655677 *31. Okt. 201623. Mai 2017Shifamed Holdings, LlcAblation catheters including a balloon and electrodes
US96620609. Okt. 201230. Mai 2017Aegea Medical Inc.Integrity testing method and apparatus for delivering vapor to the uterus
US966216319. Sept. 201130. Mai 2017Hermes Innovations LlcEndometrial ablation devices and systems
US966881123. Sept. 20116. Juni 2017Boston Scientific Scimed, Inc.Minimally invasive access for renal nerve ablation
US968716610. Okt. 201427. Juni 2017Boston Scientific Scimed, Inc.High resolution cardiac mapping electrode array catheter
US969382128. Febr. 20144. Juli 2017Boston Scientific Scimed, Inc.Medical devices for modulating nerves
US969389022. Juli 20154. Juli 2017Hologic, Inc.Variable stiffness flexure
US97003656. Okt. 200911. Juli 2017Santa Anna Tech LlcMethod and apparatus for the ablation of gastrointestinal tissue
US970703625. Juni 201418. Juli 2017Boston Scientific Scimed, Inc.Devices and methods for nerve modulation using localized indifferent electrodes
US97137304. Okt. 201225. Juli 2017Boston Scientific Scimed, Inc.Apparatus and method for treatment of in-stent restenosis
US97175578. Apr. 20141. Aug. 2017Apama Medical, Inc.Cardiac ablation catheters and methods of use thereof
US97439749. Nov. 201129. Aug. 2017Aegea Medical Inc.Positioning method and apparatus for delivering vapor to the uterus
US974397827. Nov. 201229. Aug. 2017Minerva Surgical, Inc.Systems and methods for endometrial ablation
US975719328. Apr. 201612. Sept. 2017Medtronic Ardian Luxembourg S.A.R.L.Balloon catheter apparatus for renal neuromodulation
US977060613. Okt. 201426. Sept. 2017Boston Scientific Scimed, Inc.Ultrasound ablation catheter with cooling infusion and centering basket
US977554218. Juli 20133. Okt. 2017Minerva Surgical, Inc.Apparatus for evaluating the integrity of a uterine cavity
US97888909. Apr. 201217. Okt. 2017Minerva Surgical, Inc.Methods for evaluating the integrity of a uterine cavity
US9795442 *31. Okt. 201624. Okt. 2017Shifamed Holdings, LlcAblation catheters
US980830019. Febr. 20137. Nov. 2017Boston Scientific Scimed, Inc.Control of arterial smooth muscle tone
US980831020. Dez. 20107. Nov. 2017Gynesonics, Inc.Method and device for uterine fibroid treatment
US98083114. März 20147. Nov. 2017Boston Scientific Scimed, Inc.Deflectable medical devices
US981452015. Apr. 201614. Nov. 2017Minerva Surgical, Inc.System and method for endometrial ablation
US20020198521 *6. Juni 200226. Dez. 2002Maguire Mark A.Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US20030139790 *7. Jan. 200324. Juli 2003Surx, Inc.Noninvasive devices, methods, and systems for shrinking of tissues
US20030158550 *19. Febr. 200321. Aug. 2003Ganz Robert A.Method of treating abnormal tissue in the human esophagus
US20030178032 *3. Febr. 200325. Sept. 2003Surx, Inc.Noninvasive devices, methods, and systems for shrinking of tissues
US20030199863 *22. Nov. 200223. Okt. 2003Swanson David K.Systems and methods for controlling power in an electrosurgical probe
US20040002748 *23. Okt. 20021. Jan. 2004Ethicon, Inc.Device and method to expand treatment array
US20040015162 *22. Juli 200222. Jan. 2004Medtronic Vidamed, Inc.Method for treating tissue with a wet electrode and apparatus for using same
US20040064135 *1. Okt. 20031. Apr. 2004Sampson Russell M.Apparatus and method for treating venous reflux
US20040138735 *21. Okt. 200315. Juli 2004Shaolian Samuel M.Single puncture bifurcation graft deployment system
US20040143251 *5. Jan. 200422. Juli 2004Sampson Russell M.Apparatus and method for treating venous reflux
US20040215235 *9. Jan. 200428. Okt. 2004Barrx, Inc.Methods and systems for determining physiologic characteristics for treatment of the esophagus
US20040249425 *7. Juli 20049. Dez. 2004Solarant Medical, Inc.Static devices and methods to shrink tissues for incontinence
US20040267336 *19. Apr. 200430. Dez. 2004Solarant Medical, Inc.Energy induced bulking and buttressing of tissues for incontinence
US20050059965 *15. Sept. 200317. März 2005Scimed Life Systems, Inc.Catheter balloons
US20050085804 *12. Okt. 200421. Apr. 2005Medtronic Vidamed, Inc.Method for treating tissue with a wet electrode and apparatus for using same
US20050085880 *6. Okt. 200421. Apr. 2005Csaba TruckaiMoisture transport system for contact electrocoagulation
US20050171524 *9. Jan. 20044. Aug. 2005Barrx, Inc.Devices and methods for treatment of luminal tissue
US20050171582 *30. Jan. 20044. Aug. 2005Solarant Medical, Inc.Electrically heated/phase change probe temperature control
US20050182397 *4. Febr. 200418. Aug. 2005Thomas RyanDevice and method for ablation of body cavities
US20050240211 *23. März 200527. Okt. 2005Stefan SporriApparatus and method for selectably treating a fallopian tube
US20060025758 *24. Aug. 20052. Febr. 2006Bruno StrulRadio-frequency generator for powering an ablation device
US20060167533 *21. Jan. 200527. Juli 2006Solarant Medical, Inc.Endo-pelvic fascia penetrating heating systems and methods for incontinence treatment
US20060189972 *2. Febr. 200624. Aug. 2006Gynesonics, Inc.Method and device for uterine fibroid treatment
US20060229628 *3. Okt. 200512. Okt. 2006Csaba TruckaiBiomedical treatment systems and methods
US20070129720 *14. Nov. 20067. Juni 2007Ardian, Inc.Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US20070161905 *5. Jan. 200712. Juli 2007Gynesonics, Inc.Intrauterine ultrasound and method for use
US20070179380 *5. Jan. 20072. Aug. 2007Gynesonics, Inc.Interventional deployment and imaging system
US20070249936 *28. Nov. 200625. Okt. 2007Gynesonics, Inc.Devices and methods for treatment of tissue
US20070249939 *20. Apr. 200625. Okt. 2007Gynesonics, Inc.Rigid delivery systems having inclined ultrasound and curved needle
US20080071269 *18. Sept. 200620. März 2008Cytyc CorporationCurved Endoscopic Medical Device
US20080188858 *1. Febr. 20087. Aug. 2008Robert LuzziBone treatment systems and methods
US20080281317 *10. Mai 200713. Nov. 2008Fred GobelEndometrial Ablation catheter
US20090054868 *22. Aug. 200826. Febr. 2009Sharkey Hugh RUterine Therapy Device and Method
US20090054869 *22. Aug. 200826. Febr. 2009Sharkey Hugh RUterine Therapy Device and Method
US20090054870 *22. Aug. 200826. Febr. 2009Sharkey Hugh RUterine Therapy Device and Method
US20090054871 *22. Aug. 200826. Febr. 2009Sharkey Hugh RUterine Therapy Device and Method
US20090099544 *3. Okt. 200816. Apr. 2009Gynesonics, Inc.Methods and systems for controlled deployment of needles in tissue
US20090187179 *22. Febr. 200723. Juli 2009Racz N SandorAblation Instruments and Related Methods
US20090204189 *5. Apr. 200613. Aug. 2009Tuchiyagomu Co., Ltd.Living-Tissue Normalization Method
US20090247664 *27. Febr. 20091. Okt. 2009Dfine, Inc.Bone treatment systems and methods
US20090287081 *15. Apr. 200919. Nov. 2009Gynesonics , IncSubmucosal fibroid ablation for the treatment of menorrhagia
US20100016467 *27. Febr. 200921. Jan. 2010Dfine, Inc.Bone treatment systems and methods
US20100056926 *26. Aug. 20084. März 2010Gynesonics, Inc.Ablation device with articulated imaging transducer
US20100121319 *21. Okt. 200913. Mai 2010Microcube, LlcMethods and devices for applying energy to bodily tissues
US20100125269 *21. Okt. 200920. Mai 2010Microcube, Limited Liability CorporationMicrowave treatment devices and methods
US20100137857 *21. Okt. 20093. Juni 2010Microcube, Limited Liability CorporationMethods and devices for applying energy to bodily tissues
US20100160908 *8. März 201024. Juni 2010Sampson Russel MHemostasis Device
US20100198214 *29. Jan. 20105. Aug. 2010Cytyc CorporationCervical opening sealing devices
US20110004205 *1. Juli 20106. Jan. 2011Chu Chun YiuMethods and devices for delivering microwave energy
US20110015549 *28. Sept. 201020. Jan. 2011Shimon EckhouseMethod and apparatus for treating a diseased nail
US20110054482 *9. Nov. 20103. März 2011Dfine, Inc.Composites and methods for treating bone
US20110087100 *20. Dez. 201014. Apr. 2011Gynesonics, Inc.Method and device for uterine fibroid treatment
US20110106226 *27. Jan. 20095. Mai 2011Andras SzaszFlexible and porous large-area electrode for heating
US20110112432 *11. Nov. 200912. Mai 2011Minerva Surgical, Inc.Systems and devices for evaluating the integrity of a uterine cavity
US20110112433 *11. Nov. 200912. Mai 2011Minerva Surgical, Inc.Methods for evaluating the integrity of a uterine cavity
US20110112523 *11. Nov. 200912. Mai 2011Minerva Surgical, Inc.Systems, methods and devices for endometrial ablation utilizing radio frequency
US20110118718 *13. Nov. 200919. Mai 2011Minerva Surgical, Inc.Methods and systems for endometrial ablation utilizing radio frequency
US20110152981 *23. Febr. 201123. Juni 2011Tuchiyagomu Co., Ltd.Living-tissue normalization method
US20120239028 *18. März 201120. Sept. 2012Wallace Michael PSelectively expandable operative element support structure and methods of use
US20120330298 *22. Juni 201227. Dez. 2012Tyco Healthcare Group LpSystem and method of treating abnormal tissue in the human esophagus
US20120330299 *2. Juli 201227. Dez. 2012Asthmatx, Inc.Systems and methods for delivering energy to passageways in a patient
US20120330303 *5. Sept. 201227. Dez. 2012Cytyc CorporationHemostasis Device
US20130245581 *15. März 201219. Sept. 2013Alexander James NorredPostpartum Uterine Contractile Apparatus and Method
US20130245637 *14. März 201319. Sept. 2013Inpress TechnologiesUterine hemorrhage controlling system and method
US20130296837 *23. Mai 20137. Nov. 2013Channel Medsystems, Inc.Cyrogenic treatment systems
US20140005649 *6. Sept. 20132. Jan. 2014Channel Medsystems, Inc.Handheld cyrogenic treatment systems
US20140046317 *8. Aug. 201313. Febr. 2014Cytyc Surgical ProductsMoisture Transport System for Contact Electrocoagulation
US20140058373 *19. Febr. 201327. Febr. 2014Covidien LpSystem and method of treating abnormal tissue in the human esophagus
US20140200569 *17. März 201417. Juli 2014Tsunami Medtech, LlcMedical instruments and techniques for thermally-mediated therapies
US20170042614 *31. Okt. 201616. Febr. 2017Amr SalahiehAblation catheters
US20170042615 *31. Okt. 201616. Febr. 2017Amr SalahiehAblation catheters
CN104245535A *14. März 201324. Dez. 2014因普雷斯科技公司Uterine hemorrhage controlling system and method
CN104245535B *14. März 201314. Sept. 2016因普雷斯科技公司子宫出血控制系统
EP2198797A122. Aug. 200823. Juni 2010Aegea Medical, Inc.Uterine therapy device
EP2397087A229. Jan. 201021. Dez. 2011Cytyc CorporationCervical opening sealing devices
EP2522290A222. Aug. 200814. Nov. 2012Aegea Medical, Inc.Uterine therapy device
EP2568905A4 *12. Mai 201126. Juli 2017Shifamed Holdings LlcLow profile electrode assembly
WO2000006246A1 *29. Juli 199910. Febr. 2000Surx, Inc.Static devices and methods to shrink tissues for incontinence
WO2001022895A1 *14. Sept. 20005. Apr. 2001C.R. Bard, Inc.Electrode contact evaluation and ablation system, and method of use
WO2001035844A210. Nov. 200025. Mai 2001NovaceptSystem and method for detecting perforations in a body cavity
WO2005077291A1 *26. Jan. 200525. Aug. 2005Ethicon, Inc.Device and method for ablation of body cavities
WO2006068808A1 *5. Dez. 200529. Juni 2006Cytyc CorporationMethod and system for transcervical tubal occlusion
WO2010053700A1 *21. Okt. 200914. Mai 2010Microcube, LlcMethods and devices for applying energy to bodily tissues
WO2010085460A120. Jan. 201029. Juli 2010Aegea Medical, Inc.Uterine therapy device and method
WO2011053599A126. Okt. 20105. Mai 2011Hermes Innovations LlcEndometrial ablation devices and system
WO2011060191A111. Nov. 201019. Mai 2011Minerva Surgical, Inc.Systems and devices for evaluating the integrity of a uterine cavity
WO2015100111A117. Dez. 20142. Juli 2015Hologic, Inc.Power modulated endometrial lining tissue ablation
Klassifizierungen
US-Klassifikation607/101, 604/500, 604/20, 607/116, 604/515, 604/114, 607/99
Internationale KlassifikationA61M1/00, A61B17/42, A61B18/14, A61B18/12, A61B17/22, A61M16/04
UnternehmensklassifikationA61B2090/065, A61B2017/22051, A61B2018/126, A61M16/0481, A61B18/1485, A61B2017/4216
Europäische KlassifikationA61B18/14S
Juristische Ereignisse
DatumCodeEreignisBeschreibung
12. Apr. 1996ASAssignment
Owner name: ENVISION SURGICAL SYSTEMS, CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TRUCKAI, CSABA;AUTH, DAVID C.;REEL/FRAME:007965/0554
Effective date: 19960404
27. Okt. 1997ASAssignment
Owner name: ACUVASIVE, CALIFORNIA
Free format text: CHANGE OF NAME;ASSIGNOR:ENVISION SURGICAL SYSTEMS;REEL/FRAME:008764/0919
Effective date: 19950306
Owner name: NOVACEPT, CALIFORNIA
Free format text: CHANGE OF NAME;ASSIGNOR:ACUVASIVE;REEL/FRAME:008764/0900
Effective date: 19960506
5. Okt. 1999RRRequest for reexamination filed
Effective date: 19990727
26. Dez. 2000RRRequest for reexamination filed
Effective date: 20001122
25. Juni 2001FPAYFee payment
Year of fee payment: 4
24. Aug. 2004B1Reexamination certificate first reexamination
Free format text: CLAIMS 2, 3, 17, 18 AND 23 ARE CANCELLED. CLAIMS 1, 4, 11, 13, 16, 19-22 AND 24-27 ARE DETERMINED TO BE PATENTABLE AS AMENDED. CLAIMS 5-10, 12, 14, 15 AND 28-33, DEPENDENT ON AN AMENDED CLAIM, ARE DETERMINED TO BE PATENTABLE. NEW CLAIMS 34-103 ARE ADDED AND DETERMINED TO BE PATENTABLE.
12. Nov. 2004ASAssignment
Owner name: CYTYC SURGICAL PRODUCTS, CALIFORNIA
Free format text: CHANGE OF NAME;ASSIGNOR:NOVACEPT;REEL/FRAME:015991/0624
Effective date: 20040324
27. Sept. 2005CCCertificate of correction
23. Dez. 2005FPAYFee payment
Year of fee payment: 8
26. Okt. 2007ASAssignment
Owner name: GOLDMAN SACHS CREDIT PARTNERS L.P., NEW JERSEY
Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:CYTYC SURGICAL PRODUCTS;REEL/FRAME:020018/0653
Effective date: 20071022
Owner name: GOLDMAN SACHS CREDIT PARTNERS L.P.,NEW JERSEY
Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:CYTYC SURGICAL PRODUCTS;REEL/FRAME:020018/0653
Effective date: 20071022
29. Juli 2008ASAssignment
Owner name: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL
Free format text: PATENT SECURITY AGREEMENT;ASSIGNOR:CYTYC SURGICAL PRODUCTS;REEL/FRAME:021311/0118
Effective date: 20080717
23. Dez. 2009FPAYFee payment
Year of fee payment: 12
25. Aug. 2010ASAssignment
Owner name: THIRD WAVE TECHNOLOGIES, INC., WISCONSIN
Free format text: TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS;ASSIGNOR:GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT;REEL/FRAME:024944/0315
Effective date: 20100819
Owner name: SUROS SURGICAL SYSTEMS, INC., INDIANA
Free format text: TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS;ASSIGNOR:GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT;REEL/FRAME:024944/0315
Effective date: 20100819
Owner name: DIRECT RADIOGRAPHY CORP., DELAWARE
Free format text: TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS;ASSIGNOR:GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT;REEL/FRAME:024944/0315
Effective date: 20100819
Owner name: CYTYC CORPORATION, MASSACHUSETTS
Free format text: TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS;ASSIGNOR:GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT;REEL/FRAME:024944/0315
Effective date: 20100819
Owner name: BIOLUCENT, LLC, CALIFORNIA
Free format text: TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS;ASSIGNOR:GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT;REEL/FRAME:024944/0315
Effective date: 20100819
Owner name: R2 TECHNOLOGY, INC., CALIFORNIA
Free format text: TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS;ASSIGNOR:GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT;REEL/FRAME:024944/0315
Effective date: 20100819
Owner name: HOLOGIC, INC., MASSACHUSETTS
Free format text: TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS;ASSIGNOR:GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT;REEL/FRAME:024944/0315
Effective date: 20100819
Owner name: CYTYC PRENATAL PRODUCTS CORP., MASSACHUSETTS
Free format text: TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS;ASSIGNOR:GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT;REEL/FRAME:024944/0315
Effective date: 20100819
Owner name: CYTYC SURGICAL PRODUCTS III, INC., MASSACHUSETTS
Free format text: TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS;ASSIGNOR:GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT;REEL/FRAME:024944/0315
Effective date: 20100819
Owner name: CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP, MA
Free format text: TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS;ASSIGNOR:GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT;REEL/FRAME:024944/0315
Effective date: 20100819
Owner name: CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP, MASSA
Free format text: TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS;ASSIGNOR:GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT;REEL/FRAME:024944/0315
Effective date: 20100819
1. Aug. 2012ASAssignment
Owner name: GOLDMAN SACHS BANK USA, NEW YORK
Free format text: SECURITY AGREEMENT;ASSIGNORS:HOLOGIC, INC.;BIOLUCENT, LLC;CYTYC CORPORATION;AND OTHERS;REEL/FRAME:028810/0745
Effective date: 20120801
4. Juni 2015ASAssignment
Owner name: GEN-PROBE INCORPORATED, MASSACHUSETTS
Free format text: SECURITY INTEREST RELEASE REEL/FRAME 028810/0745;ASSIGNOR:GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT;REEL/FRAME:035820/0239
Effective date: 20150529
Owner name: CYTYC CORPORATION, MASSACHUSETTS
Free format text: SECURITY INTEREST RELEASE REEL/FRAME 028810/0745;ASSIGNOR:GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT;REEL/FRAME:035820/0239
Effective date: 20150529
Owner name: SUROS SURGICAL SYSTEMS, INC., MASSACHUSETTS
Free format text: SECURITY INTEREST RELEASE REEL/FRAME 028810/0745;ASSIGNOR:GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT;REEL/FRAME:035820/0239
Effective date: 20150529
Owner name: HOLOGIC, INC., MASSACHUSETTS
Free format text: SECURITY INTEREST RELEASE REEL/FRAME 028810/0745;ASSIGNOR:GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT;REEL/FRAME:035820/0239
Effective date: 20150529
Owner name: BIOLUCENT, LLC, MASSACHUSETTS
Free format text: SECURITY INTEREST RELEASE REEL/FRAME 028810/0745;ASSIGNOR:GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT;REEL/FRAME:035820/0239
Effective date: 20150529
Owner name: THIRD WAVE TECHNOLOGIES, INC., MASSACHUSETTS
Free format text: SECURITY INTEREST RELEASE REEL/FRAME 028810/0745;ASSIGNOR:GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT;REEL/FRAME:035820/0239
Effective date: 20150529
Owner name: CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP, MASS
Free format text: SECURITY INTEREST RELEASE REEL/FRAME 028810/0745;ASSIGNOR:GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT;REEL/FRAME:035820/0239
Effective date: 20150529
7. Aug. 2015ASAssignment
Owner name: BANK OF AMERICA, N.A., AS COLLATERAL AGENT, NORTH
Free format text: SECURITY AGREEMENT;ASSIGNORS:HOLOGIC, INC.;BIOLUCENT, LLC;CYTYC CORPORATION;AND OTHERS;REEL/FRAME:036307/0199
Effective date: 20150529